The DOI matches its Crossref record; 335 of the 335 references it cites were found in a registry or an index.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder
Abstract
OBJECTIVES: Although clinically highly relevant, the recognition and treatment of bipolar mixed states has played only an underpart in recent guidelines. This WFSBP guideline has been developed to supply a systematic overview of all scientific evidence pertaining to the acute and long-term treatment of bipolar mixed states in adults. METHODS: Material used for these guidelines is based on a systematic literature search using various data bases. Their scientific rigour was categorised into six levels of evidence (A-F), and different grades of recommendation to ensure practicability were assigned. We examined data pertaining to the acute treatment of manic and depressive symptoms in bipolar mixed patients, as well as data pertaining to the prevention of mixed recurrences after an index episode of any type, or recurrence of any type after a mixed index episode. RESULTS: Manic symptoms in bipolar mixed states appeared responsive to treatment with several atypical antipsychotics, the best evidence resting with olanzapine. For depressive symptoms, addition of ziprasidone to treatment as usual may be beneficial; however, the evidence base is much more limited than for the treatment of manic symptoms. Besides olanzapine and quetiapine, valproate and lithium should also be considered for recurrence prevention. LIMITATIONS: The concept of mixed states changed over time, and recently became much more comprehensive with the release of DSM-5. As a consequence, studies in bipolar mixed patients targeted slightly different bipolar subpopulations. In addition, trial designs in acute and maintenance treatment also advanced in recent years in response to regulatory demands. CONCLUSIONS: Current treatment recommendations are still based on limited evidence, and there is a clear demand for confirmative studies adopting the DSM-5 specifier with mixed features concept.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is also congruent with current recommendations for augmentation in patients with unipolar TRD by the World Federation of Societies of Biological Psychiatry Task Force which considers lithium as first-line agent and aripiprazole and quetiapine as alternatives (Grunze et al., 2018).”
From Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis (2022) · cites this paper as Grunze et al., 2018
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
Diagnostic and Statistical Manual of Mental Disorders, 3rd ed
COOPER, A. M., & MICHELS, R. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.128 · Cited by 7,356
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Self-citationSelective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435 · cited 2×
“The task force is aware of several inherent limitations of these guidelines: namely publication bias (Turner et al. 2008; Flint et al. 2015), sponsor bias (Lundh et al.”
BackgroundGrande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309 · cited 5×
“This decision of the task force is also in line with their appreciation in other recent bipolar guidelines, such as the British Association for Psychopharmacology guideline (Goodwin et al. 2016).”
MethodResultInfluentialSelf-citationA consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914 · cited 1×
“Post hoc secondary analyses play a prominent role in studies including manic and mixed manic patients but bear the risk of inflating the chance of false-positive findings (Oxman and Guyatt 1992).”
BackgroundTohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citation
Research works printed but not linked: 33
- Akiskal HS., 1994, J Clin Psychiatry, 55, 46
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
- Baillarger J., 1854, Folie à double forme
- 10.1001/jama.271.12.918 · doi:10.1001/jama.271.12.918 · Paper page
- Cipriani A, 2013, Cochrane Database Syst Rev, 10, CD003196
- Citrome L., 2014, Expert Opin Drug Saf, 13, 803
- Ernst CL, 2002, J Clin Psychiatry, 63, 42
- Falret JP., 1854, Bull Acad Natl Méd, 19, 382
- Garcia-Bonetto GM, 2009, Archivos De Neurosci, 14, 215
- Himmelhoch JM, 1986, Psychopharmacol Bull, 22, 613
- Kraepelin E., 1899, Ein Lehrbuch für Studierende und Ärzte
- Mazzarini L, 2017, J Affect Disord
- McIntyre RS, 2011, Prim Care Companion CNS Disord, 13, CC
- Mokhber N, 2008, Neuropsychiatr Dis Treat, 4, 227
- Mosolov SN, 2009, Zh Nevrol Psikhiatr Im S S Korsakova, 109, 47
- Mosolov SN, 2009, Zh Nevrol Psikhiatr Im S S Korsakova, 109, 36
- Mosolov SN, 1990, Zh Nevropatol Psikhiatr Im S S Korsakova, 90, 121
- Mosolov SN., 1991, Zh Nevropatol Psikhiatr Im S S Korsakova, 91, 78
- Palma M, 2016, Depress Res Treat, 2016, 8306071
- Pichot P., 2004, Bull Acad Natl Med, 188, 275
- Pigott K, 2016, Cochrane Database Syst Rev, 9, CD003384
- Sharma V, 1999, J Psychiatry Neurosci, 24, 40
- 10.3109/10401239909147073 · doi:10.3109/10401239909147073
- Spitzer RL, 1975, Research diagnostic criteria (RDC) for a selected group of functional disorders
- Strejilevich SA, 2011, Ann Clin Psychiatry, 23, 186
- Strömgren LS., 1988, Convuls Ther, 4, 306
- Vanelle JM, 1994, Convuls Ther, 10, 195
- Vieta E, 1995, Int J Neuropsychopharmacol, 10, 491
- Whittier MC, 1995, J Clin Psychiatry, 56, 590
- Wilhelm S, 2007, Eur Psychiatry, 22, S 262
- World Health Organization, 1992, Clinical descriptions and diagnostic guidelines
- Zeeuws D, 2010, Psychiatr Danub, 22, S135
- Zeeuws D, 2010, Psychiatr Danub, 22, S164
Cited by
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047
Self-citationMcAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278
Self-citationStahl, S. M., Laredo, S., & Morrissette, D. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320905752 · Cited by 223
Nuñez, N. A., Joseph, B., Pahwa, M., Kumar, R., Resendez, M. G., Prokop, L. J., Veldic, M., Seshadri, A., Biernacka, J. M., Frye, M. A., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.134 · Cited by 215
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M. (2020) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s259338 · Cited by 147
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Azorin, J.-M., Yatham, L., Mosolov, S., Möller, H.-J., Kasper, S., & on behalf of the Members of the WFSBP Task Force on Bipolar Affective Disorders Working on this topic
- Affiliations
- Klinikum am Weissenhof (DE)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Warneford Hospital (GB)
- The University of Texas at San Antonio Health Science Center (US)
- Aalborg University Hospital (DK)
- Hôpital Sainte-Marguerite (FR)
- University of British Columbia (CA)
- Department for Therapy of Mental Disorders, Moscow Research Institute of Psychiatry, Moscow, Russia;
- Ludwig-Maximilians-Universität München (DE)
- Medical University of Vienna (AT)
- Corresponding author
- Grunze, Heinz
- ORCID
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2017-11-03
- Volume
- 19
- Issue
- 1
- Pages
- 2-58
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2766127294
- Cited by
- 187
- References
- 335
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 16 · 2023: 19 · 2022: 24 · 2021: 28 · 2020: 30 · 2019: 25 · 2018: 10 · 2017: 1
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- HAL AMU (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0513-10010)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- bipolar disorder, acute treatment, long-term maintenance therapy, atypical antipsychotics, olanzapine, quetiapine, ziprasidone, valproic acid, lithium, recurrence prevention, manic symptoms, depressive symptoms
- MeSH terms
- Biological Psychiatry, Bipolar Disorder, Electroconvulsive Therapy, Humans, Societies, Medical, Antipsychotic Agents, Practice Guidelines as Topic, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. https://app.cochat.ai/papers/10.1080/15622975.2017.1384850
- The paper
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Azorin, J.-M., Yatham, L., Mosolov, S., Möller, H.-J., Kasper, S., & on behalf of the Members of the WFSBP Task Force on Bipolar Affective Disorders Working on this topic. (2018). The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2017.1384850
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.